Accessibility Menu
 
Eastwood Bio-Medical Canada logo

Eastwood Bio-Medical Canada

(TSXV) EBM

Current Price$0.61
Market Cap$48.22M
Since IPO (2014)+75%
5 Year-60%
1 Year+56%
1 Month+30%

Eastwood Bio-Medical Canada Financials at a Glance

Market Cap

$48.22M

Revenue (TTM)

$719.58K

Net Income (TTM)

$312.31K

EPS (TTM)

$-0.00

P/E Ratio

-155.56

Dividend

$0.00

Beta (Volatility)

-0.29 (Low)

Price

$0.61

Volume

7,560

Open

$0.68

Previous Close

$0.70

Daily Range

$0.61 - $0.68

52-Week Range

$0.29 - $1.10

EBM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eastwood Bio-Medical Canada

Industry

Healthcare Providers and Services

CEO

Youngsoo Kim, PhD

Headquarters

Richmond, BC V6X 3Z6, CA

EBM Financials

Key Financial Metrics (TTM)

Gross Margin

63%

Operating Margin

-58%

Net Income Margin

-63%

Return on Equity

0%

Return on Capital

60%

Return on Assets

-1%

Earnings Yield

-0.64%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$48.22M

Shares Outstanding

68.89M

Volume

7.56K

Short Interest

0.00%

Avg. Volume

4.84K

Financials (TTM)

Gross Profit

$506.03K

Operating Income

$354.70K

EBITDA

$309.73K

Operating Cash Flow

$19.30K

Capital Expenditure

$3.00

Free Cash Flow

$19.30K

Cash & ST Invst.

$17.70K

Total Debt

$78.01K

Eastwood Bio-Medical Canada Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$152.22K

-29.1%

Gross Profit

$93.72K

-41.1%

Gross Margin

61.57%

N/A

Market Cap

$48.22M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$20.73K

+49.7%

EBITDA

$30.00K

-728.4%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$61.20K

+17.4%

Accounts Receivable

$61.29K

+592.4%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$74.67K

-9.8%

Return on Assets

-1.12%

N/A

Return on Invested Capital

60.09%

N/A

Free Cash Flow

$900.00

-121.9%

Operating Cash Flow

$900.00

-121.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SWP.TOSwiss Water Decaffeinated Coffee Inc.
$4.78-1.65%
JSDA.CNJones Soda Co.
$0.36-1.37%
OPTI.CNOptimi Health Corp.
$0.35+16.67%
BU.TOBurcon NutraScience Corporation
$2.37+7.73%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$65.58-0.04%
TSLATesla
$392.87-0.02%
AALAmerican Airlines Group
$12.23-0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.61-0.00%

Questions About EBM

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.